More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

ASCO’s updated guidelines for advanced ovarian cancer emphasize health equity and provide new recommendations for HIPEC while ...

As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced the appointment of Tobin "Toby” Schilke as chief financial ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

Crinetics Pharmaceuticals said it has hired the chief financial officer of Revance Therapeutics to replace its outgoing finance chief. The clinical-stage pharmaceutical company said Monday that Tobin ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

Kodiak Sciences uses a novel biopolymer conjugate platform to develop more durable, next-generation retinal disease therapies ...

The US FDA has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy.

The Global Recombinant DNA Technology Market was valued at approximately USD $$ billion in 2022 and is expected to grow at a healthy CAGR of over $% from 2023 to 2030. Recombinant DNA Technology ...

Biosion, Inc. ("Biosion"), a global clinical-stage biotechnology company, is pleased to announce the appointment of Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US. With ...